DK1509215T3 - Behandling eller forebyggelse af urogenital atrofi og dets symptomer hos kvinder - Google Patents

Behandling eller forebyggelse af urogenital atrofi og dets symptomer hos kvinder

Info

Publication number
DK1509215T3
DK1509215T3 DK03725238T DK03725238T DK1509215T3 DK 1509215 T3 DK1509215 T3 DK 1509215T3 DK 03725238 T DK03725238 T DK 03725238T DK 03725238 T DK03725238 T DK 03725238T DK 1509215 T3 DK1509215 T3 DK 1509215T3
Authority
DK
Denmark
Prior art keywords
women
prevention
treatment
symptoms
atrophy
Prior art date
Application number
DK03725238T
Other languages
Danish (da)
English (en)
Inventor
Taru Blom
Paula Groenroos
Kaija Halonen
Pirkko Haerkoenen
Original Assignee
Hormos Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hormos Medical Ltd filed Critical Hormos Medical Ltd
Application granted granted Critical
Publication of DK1509215T3 publication Critical patent/DK1509215T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
DK03725238T 2002-06-06 2003-05-14 Behandling eller forebyggelse af urogenital atrofi og dets symptomer hos kvinder DK1509215T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38590402P 2002-06-06 2002-06-06
PCT/FI2003/000369 WO2003103649A1 (en) 2002-06-06 2003-05-14 Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women

Publications (1)

Publication Number Publication Date
DK1509215T3 true DK1509215T3 (da) 2007-03-12

Family

ID=29736123

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03725238T DK1509215T3 (da) 2002-06-06 2003-05-14 Behandling eller forebyggelse af urogenital atrofi og dets symptomer hos kvinder

Country Status (24)

Country Link
EP (1) EP1509215B1 (pt)
JP (1) JP4362442B2 (pt)
KR (1) KR100991157B1 (pt)
CN (2) CN101406464A (pt)
AT (1) ATE344025T1 (pt)
AU (1) AU2003227790B2 (pt)
BR (1) BR0311613A (pt)
CA (1) CA2484542C (pt)
CY (1) CY1105787T1 (pt)
DE (1) DE60309465T2 (pt)
DK (1) DK1509215T3 (pt)
ES (1) ES2270025T3 (pt)
HR (1) HRP20041150B1 (pt)
IL (1) IL164528A (pt)
MX (1) MXPA04012220A (pt)
NO (3) NO334090B1 (pt)
NZ (1) NZ536118A (pt)
PL (1) PL214242B1 (pt)
PT (1) PT1509215E (pt)
RU (1) RU2317816C2 (pt)
SI (1) SI1509215T1 (pt)
UA (1) UA79797C2 (pt)
WO (1) WO2003103649A1 (pt)
ZA (1) ZA200408321B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236861B2 (en) 2004-02-13 2012-08-07 Hormos Medical Corporation Method for enhancing the bioavailablity of ospemifene
US8642079B2 (en) 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
US8758821B2 (en) 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
ES2392344T3 (es) 2004-05-04 2012-12-07 Hormos Medical Ltd. Formulaciones orales líquidas de ospemifeno
JP5193196B2 (ja) 2006-06-02 2013-05-08 ペア ツリー ウーマンズ ヘルス ケア 萎縮性膣炎の治療の方法
EP2121553B1 (en) 2007-02-14 2012-06-27 Hormos Medical Ltd. Method for the preparation of therapeutically valuable triphenylbutene derivatives
US7504530B2 (en) 2007-02-14 2009-03-17 Hormos Medical Ltd. Methods for the preparation of fispemifene from ospemifene
JP6174156B2 (ja) 2012-10-19 2017-08-02 フェルミオン オサケ ユキチュア オスペミフェンの製造方法
KR102052133B1 (ko) 2017-08-10 2019-12-05 고려대학교 산학협력단 당 부가된 오스페미펜, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352699A (en) * 1992-04-30 1994-10-04 University Of Massachusetts Medical Center Use of retinioc acid to treat vaginal atrophy
US5461064A (en) * 1993-12-21 1995-10-24 Eli Lilly And Company Methods of inhibiting atrophy of the skin and vagina
US5747059A (en) * 1996-01-11 1998-05-05 Novo Nordisk A/S Atrophy of skin/mucous membrane
KR20020073566A (ko) * 2000-01-28 2002-09-27 앙도르쉐르슈 인코포레이티드 에스트로겐과 배합된 선택적인 에스트로겐 수용체 조절자
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
US6245819B1 (en) * 2000-07-21 2001-06-12 Hormos Medical Oy, Ltd. Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause

Also Published As

Publication number Publication date
HRP20041150B1 (en) 2007-06-30
JP2005532353A (ja) 2005-10-27
IL164528A (en) 2010-06-30
IL164528A0 (en) 2005-12-18
RU2317816C2 (ru) 2008-02-27
EP1509215A1 (en) 2005-03-02
CY1105787T1 (el) 2011-02-02
ES2270025T3 (es) 2007-04-01
BR0311613A (pt) 2005-03-08
NO20150487L (no) 2004-12-22
NO339194B1 (no) 2016-11-14
AU2003227790A1 (en) 2003-12-22
AU2003227790B2 (en) 2007-11-29
NO336612B1 (no) 2015-10-12
PL372758A1 (en) 2005-08-08
KR100991157B1 (ko) 2010-11-02
CN101406464A (zh) 2009-04-15
CA2484542C (en) 2010-11-02
RU2004138571A (ru) 2005-06-10
NO20044568L (no) 2004-12-22
SI1509215T1 (sl) 2007-02-28
ATE344025T1 (de) 2006-11-15
MXPA04012220A (es) 2005-04-08
PL214242B1 (pl) 2013-07-31
DE60309465T2 (de) 2007-08-30
WO2003103649A1 (en) 2003-12-18
CN1658851A (zh) 2005-08-24
JP4362442B2 (ja) 2009-11-11
HRP20041150A2 (en) 2006-03-31
CN100448437C (zh) 2009-01-07
EP1509215B1 (en) 2006-11-02
UA79797C2 (en) 2007-07-25
NO20131189L (no) 2004-12-22
DE60309465D1 (de) 2006-12-14
CA2484542A1 (en) 2003-12-18
KR20050004292A (ko) 2005-01-12
NZ536118A (en) 2007-08-31
NO334090B1 (no) 2013-12-09
ZA200408321B (en) 2006-07-26
PT1509215E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
PT1305014E (pt) Metodo para o tratamento de disturbios climatericos em mulheres durante ou apos a menopausa
PL361404A1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
DK1638569T3 (da) Anvendelse af brimonidin til at forebygge og nedsætte alvorligheden af med stress forbundne tilstande
IS7928A (is) Sertakónasóllyfjablöndur til notkunar í leggöng
NO20060278L (no) Piperazinderivater og fremgangsmater for anvendelse
SE0301886D0 (sv) New use V
SE0301888D0 (sv) New use VII
TNSN06138A1 (fr) Inhibitors of the mutant form of kit
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
PH12021550958A1 (en) Trifluoromethyl-substituted sulfonamide as bcl-2-selective inhibitor
ATE539749T1 (de) Dextromethorphan für die behandlung von akne
DK1509215T3 (da) Behandling eller forebyggelse af urogenital atrofi og dets symptomer hos kvinder
WO2003092608A3 (en) Methionine aminopeptidase-2 inhibitors and methods of use thereof
ATE308540T1 (de) Antithrombosemittel
SE0301883D0 (sv) New use II
SE0301884D0 (sv) New use III
SE0301885D0 (sv) New use IV
ATE346080T1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
DK1536777T3 (da) Anvendelse af NF-KB-inhibitorer til behandling af mastitis
SE0103539D0 (sv) New Use
ECSP993168A (es) Composicion y metodo para tratar enfermedades alergicas